Chandran Sunitha, Babu S Suresh, Vs Hari Krishnan, Varma H K, John Annie
Transmission Electron Microscope Laboratory, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Thiruvananthapuram, India.
Bioceramic Laboratory, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Thiruvananthapuram, India.
J Biomater Appl. 2016 Oct;31(4):499-509. doi: 10.1177/0885328216647197. Epub 2016 May 9.
Excessive demineralization in osteoporotic bones impairs its self-regeneration potential following a defect/fracture and is of great concern among the aged population. In this context, implants with inherent osteogenic ability loaded with therapeutic ions like Strontium (Sr) may bring forth promising outcomes. Micro-granular Strontium incorporated Hydroxyapatite scaffolds have been synthesized and in vivo osteogenic efficacy was evaluated in a long-term osteoporosis-induced aged (LOA) rat model. Micro-granules with improved surface area are anticipated to resorb faster and together with the inherent bioactive properties of Hydroxyapatite with the leaching of Strontium ions from the scaffold, osteoporotic bone healing may be promoted. Long-term osteoporosis-induced aged rat model was chosen to extrapolate the results to clinical osteoporotic condition in the aged. Micro-granular 10% Strontium incorporated Hydroxyapatite synthesized by wet precipitation method exhibited increased in vitro dissolution rate and inductively coupled plasma studies confirmed Strontium ion release of 0.01 mM, proving its therapeutic potential for osteoporotic applications. Wistar rats were induced to long-term osteoporosis-induced aged model by ovariectomy along with a prolonged induction period of 10 months. Thereafter, osteogenic efficacy of Strontium incorporated Hydroxyapatite micro-granules was evaluated in femoral bone defects in the long-term osteoporosis-induced aged model. Post eight weeks of implantation in vivo regeneration efficacy ratio was highest in the Strontium incorporated Hydroxyapatite implanted group (0.92 ± 0.04) compared to sham and Hydroxyapatite implanted group. Micro CT evaluation further substantiated the improved osteointegration of Strontium incorporated Hydroxyapatite implants from the density histograms. Thus, the therapeutical potential of micro-granular Strontium incorporated Hydroxyapatite scaffolds becomes relevant, especially as bone void fillers in osteoporotic cases of tumor resection or trauma.
骨质疏松性骨中的过度脱矿会损害其在缺损/骨折后的自我再生潜力,这在老年人群中备受关注。在这种情况下,负载锶(Sr)等治疗性离子且具有固有成骨能力的植入物可能会带来有前景的结果。已合成了含微颗粒锶的羟基磷灰石支架,并在长期骨质疏松诱导老龄(LOA)大鼠模型中评估了其体内成骨功效。预期具有更大表面积的微颗粒会更快吸收,并且随着羟基磷灰石的固有生物活性特性以及锶离子从支架中浸出,可能会促进骨质疏松性骨愈合。选择长期骨质疏松诱导老龄大鼠模型以将结果外推至老年临床骨质疏松状况。通过湿沉淀法合成的含10%锶的微颗粒羟基磷灰石表现出体外溶解速率增加,电感耦合等离子体研究证实锶离子释放量为0.01 mM,证明了其在骨质疏松应用中的治疗潜力。通过卵巢切除术诱导Wistar大鼠建立长期骨质疏松诱导老龄模型,并延长诱导期至10个月。此后,在长期骨质疏松诱导老龄模型的股骨骨缺损中评估含锶羟基磷灰石微颗粒的成骨功效。体内植入八周后,与假手术组和羟基磷灰石植入组相比,含锶羟基磷灰石植入组的再生功效比最高(0.92±0.04)。微型CT评估从密度直方图进一步证实了含锶羟基磷灰石植入物的骨整合改善情况。因此,含微颗粒锶的羟基磷灰石支架的治疗潜力变得至关重要,尤其是作为肿瘤切除或创伤的骨质疏松病例中的骨缺损填充材料。